title: Value in prostate cancer treatment.
abstract: Value in health care is measured by outcomes and expense. An agreed upon desirable outcome can be indexed against the health care expenditure required for procurement. Prostate cancer treatment is an especially difficult subject for investigation of value. The late onset of the disease, coupled with competitive mortality risk, confounds value analysis. When cost considerations are made paramount, observation is the apparent treatment of choice. J. Surg. Oncol. 2016;114:288-290. © 2016 Wiley Periodicals, Inc.
authors.affiliation: Department of Urology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
authors.forename: Robert R
authors.initials: RR
authors.lastname: Bahnson
mesh_terms: D003362:Cost-Benefit Analysis; D006801:Humans; D008297:Male; D017063:Outcome Assessment, Health Care; D011471:Prostatic Neoplasms / Q000191:economics* / Q000401:mortality / Q000628:therapy*; D011788:Quality of Life
keywords: cancer; outcomes; prostate; surgery; value